Direct line: 1300 987 995
Feb 6 (Reuters) - Prima BioMed Ltd
* Says multiple jurisdictions have approved its amended can-004 protocol including regulators in Latvia, Lithuania, Bulgaria, Ukraine and Belarus
* Source text for Eikon
* ((For more news, please click here
((Bangalore Newsroom; +91 80 6749 1130))